Bone Marrow Transplant
|Recruiting||Patients undergoing bone marrow transplant||N/A||
This clinical trial is studying computer-guided glucose management systems in treating patients with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided glucose management system (CGGMS) may help manage glucose levels in patients who have undergone blood or bone marrow transplant.
- Post-transplant adult patients (age >= 18 years) on the bone marrow transplant (BMT) Service at University of Washington medical center (UWMC)
Requiring insulin secondary to:
- Known history of (h/o) type 2 diabetes mellitus
- Two blood sugar values > 180 (point of care and/or am lab glycemia)
- One blood sugar value > 250 (point of care or AM lab glycemia)
- Critically ill patients (intensive care unit [ICU] admissions)
- Terminally ill patients
- Eastern Cooperative Oncology Group (ECOG) performance status > 3
- Previous type 1 diabetes mellitus
- Cognitively impaired patients, unable to consent
- Women of childbearing potential not on 2 different forms of contraception
See this trial at ClinicalTrials.gov
Access protocol and consent forms at Fred Hutchinson Cancer Research Center
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.